In 2024, we worked on behalf of Business Group members to represent employer interests before the U.S. Administration, regulators, legislators and other key stakeholders.

We began the year advocating for greater transparency, fair dealing, competition and innovation to ensure affordability of, and value within, employer-sponsored health plans. We also issued policy positions on Medicare payment delivery and reform, prescription drug pricing and pharmaceutical supply chain reform and transparency.

The Business Group supported a balanced approach to continued implementation of the No Surprises Act that would bring greater clarity for patients, promote prompt and efficient payment resolution and reduce independent dispute resolution (IDR) processes.

We acknowledged ERISA's 50th anniversary and advocated for ERISA preemption as well as providing guidance to the House HELP subcommittee. We further monitored developments on challenges to the law’s fiduciary duty component.

We carefully monitored the U.S. Supreme Court’s (SCOTUS) new 2024 term and the health care related cases and regulations brought under judicial review. Business Group on Health continues to support employers by educating them on potential implications for their plans. We continue to monitor impacts from the 2024 U.S. Election, including cabinet appointments and policy implications for members.